9-34343402-CAAG-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PM4_Supporting
The NM_001161.5(NUDT2):c.410_412delAAG(p.Glu137del) variant causes a disruptive inframe deletion change. The variant allele was found at a frequency of 0.00000412 in 1,456,532 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (no stars).
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000041 ( 0 hom. )
Consequence
NUDT2
NM_001161.5 disruptive_inframe_deletion
NM_001161.5 disruptive_inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 3.72
Genes affected
NUDT2 (HGNC:8049): (nudix hydrolase 2) This gene encodes a member of the MutT family of nucleotide pyrophosphatases, a subset of the larger NUDIX hydrolase family. The gene product possesses a modification of the MutT sequence motif found in certain nucleotide pyrophosphatases. The enzyme asymmetrically hydrolyzes Ap4A to yield AMP and ATP and is responsible for maintaining the intracellular level of the dinucleotide Ap4A, the function of which has yet to be established. This gene may be a candidate tumor suppressor gene. Alternative splicing has been observed at this locus and four transcript variants, all encoding the same protein, have been identified. [provided by RefSeq, Sep 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PM4
Nonframeshift variant in NON repetitive region in NM_001161.5. Strenght limited to Supporting due to length of the change: 1aa.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NUDT2 | NM_001161.5 | c.410_412delAAG | p.Glu137del | disruptive_inframe_deletion | 5/5 | ENST00000379158.7 | NP_001152.1 | |
NUDT2 | NM_001244390.2 | c.410_412delAAG | p.Glu137del | disruptive_inframe_deletion | 3/3 | NP_001231319.1 | ||
NUDT2 | NM_147172.3 | c.410_412delAAG | p.Glu137del | disruptive_inframe_deletion | 5/5 | NP_671701.1 | ||
NUDT2 | NM_147173.3 | c.410_412delAAG | p.Glu137del | disruptive_inframe_deletion | 4/4 | NP_671702.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NUDT2 | ENST00000379158.7 | c.410_412delAAG | p.Glu137del | disruptive_inframe_deletion | 5/5 | 3 | NM_001161.5 | ENSP00000368455.1 | ||
NUDT2 | ENST00000346365.8 | c.410_412delAAG | p.Glu137del | disruptive_inframe_deletion | 4/4 | 1 | ENSP00000344187.4 | |||
NUDT2 | ENST00000379155.9 | c.410_412delAAG | p.Glu137del | disruptive_inframe_deletion | 5/5 | 3 | ENSP00000368452.5 | |||
NUDT2 | ENST00000618590.1 | c.410_412delAAG | p.Glu137del | disruptive_inframe_deletion | 3/3 | 3 | ENSP00000482384.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD3 exomes AF: 0.00000809 AC: 2AN: 247368Hom.: 0 AF XY: 0.00000748 AC XY: 1AN XY: 133760
GnomAD3 exomes
AF:
AC:
2
AN:
247368
Hom.:
AF XY:
AC XY:
1
AN XY:
133760
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000412 AC: 6AN: 1456532Hom.: 0 AF XY: 0.00000414 AC XY: 3AN XY: 723832
GnomAD4 exome
AF:
AC:
6
AN:
1456532
Hom.:
AF XY:
AC XY:
3
AN XY:
723832
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Intellectual developmental disorder with or without peripheral neuropathy Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Foundation for Research in Genetics and Endocrinology, FRIGE's Institute of Human Genetics | Dec 31, 2024 | A homozygous three base pair deletion (c.410_412del) in exon 5 of the NUDT2 gene that results in deletion of amino acid glutamic acid at codon 137 was detected (p.Glu137del). This variant has not been reported in the 1000 genomes and has a MAF of 0.0004% in the gnomAD database. The in-silico prediction of the variant is damaging MutationTaster2. The reference region is conserved across species. In summary, the variant meets our criteria to be classified as a variant of uncertain significance. - |
Uncertain significance, no assertion criteria provided | research | Houlden Lab, UCL Institute of Neurology | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at